ZURBALIA Trademark

Trademark Overview


On Thursday, August 31, 2017, a trademark application was filed for ZURBALIA with the United States Patent and Trademark Office. The USPTO has given the ZURBALIA trademark a serial number of 87591319. The federal status of this trademark filing is REGISTERED as of Tuesday, October 30, 2018. This trademark is owned by Glaxo Group Limited. The ZURBALIA trademark is filed in the Pharmaceutical Products category with the following description:

(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
zurbalia

General Information


Serial Number87591319
Word MarkZURBALIA
Filing DateThursday, August 31, 2017
Status700 - REGISTERED
Status DateTuesday, October 30, 2018
Registration Number5593249
Registration DateTuesday, October 30, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 14, 2018

Trademark Statements


Goods and Services(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "ZURBALIA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 8, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events


Event DateEvent Description
Monday, October 30, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 9, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 9, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 9, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, November 9, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 9, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 30, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, August 14, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 14, 2018PUBLISHED FOR OPPOSITION
Wednesday, July 25, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 11, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 27, 2018NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 27, 2018LETTER OF SUSPENSION E-MAILED
Wednesday, June 27, 2018SUSPENSION LETTER WRITTEN
Wednesday, June 6, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 6, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 31, 2018ASSIGNED TO LIE
Thursday, May 24, 2018TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, December 7, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, December 7, 2017NON-FINAL ACTION E-MAILED
Thursday, December 7, 2017NON-FINAL ACTION WRITTEN
Wednesday, December 6, 2017ASSIGNED TO EXAMINER
Friday, September 8, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, September 4, 2017NEW APPLICATION ENTERED